Moscow, Russia – Announcing that they have developed more than 90 percent of the vaccine to protect against coronavirus, Prof Dr Uğur Şahin and his wife Dr Özlem Türeci became the hope of the whole world. ” We are on the verge of ending this epidemic, “said Prof Dr Sahin, the” savior of the world crisis.” It was announced that the Covid-19 vaccine, developed by BioNTech and US-based pharmaceutical company Pfizer, would be below market value. After this flash development in the coronavirus vaccine, we just received news of the vaccine from Russia. Russia has taken a critical step to take the lead in the vaccine race by announcing the effect of the vaccine it has developed, called Sputnik V.

The hot development in the coronavirus Vaccine Race is once again on the world agenda! A preliminary report by Pfizer and BioNTech said that the vaccine they developed had a 90 percent protective effect and no significant side effects were reported, a development that could change the course of the outbreak.

After Pfizer and BioNTech announced the vaccine, Russia did not immediately delay making a vaccine move. Breaking news about the Sputnik V vaccine developed by Russia has just been announced.

Russia is also one of the countries developing the coronavirus vaccine. The first announcement about the coronavirus vaccine, Sputnik V, developed by Russia at the Gamalaya Institute, was made by President Putin; the news was met with skepticism on the grounds that there were not enough clinical studies on the vaccine.

A flash vaccine announcement also came from Russia after Pfizer and BioNTech announced that the vaccine developed was 90 percent effective. Russia has announced that its vaccines, called Sputnik V, have a 92 percent effect.

In Phase 3 clinical trials conducted at gamalaya, it was reported that the vaccine was tested on more than 49 thousand people in 29 separate clinics in Moscow. Russia also reportedly tried the vaccine, called Sputnik V, in more than 10 thousand employees working on critical tasks.

The Sputnik V vaccine contains adenoviruses called Ad5 and Ad26, which are also used in a normal flu vaccine, and is administered in 2 doses 21 days apart.

With the world on its knees in the coronavirus epidemic, and record numbers of cases in almost every country have begun to rise, the news about the vaccine work has finally arrived. According to breaking news, Phase 3 trials of the vaccine developed by pharmaceutical companies Pfizer and BioNTech against Kovid-19 were announced to be 90 percent effective.

The Coronavirus outbreak continues to spread around the world. The total number of cases detected in the outbreak of the new type of coronavirus (Covid-19), which occurred in Wuhan, Hubey province, China and spread around the world, exceeded 51 million 243 thousand.

The coronavirus vaccine developed by BioNTech and American pharmaceutical giant Pfizer, led by Prof Dr Uğur Şahin and his wife Dr Özlem Türeci, based in Mainz, Germany, gave the world hope in an instant.

It reinforced expectations that the epidemic would finally be defeated and that the normal life that was missed was not far away. At a time when cases are running to a new record every day, people are desperate that it will take years to find an effective vaccine, and economic circles are beginning to calculate the next year as a lost year, the news about the vaccine has excited science, the economy and people.

Germany is especially proud that such a vaccine has been developed in Germany, while Prof Uğur Şahin and his wife Dr Özlem Türeci, who signed the vaccine, are immigrants, showed how pointless the discussions against immigrants have been recently, how much labor migration has contributed to Germany.

Scientists also stressed that the vaccine, developed under the leadership of Prof Sahin, is very promising. Head of The Department of Infectious Diseases of The University of Cologne Prof Gerd Faetkenheuer “these data are very excellent and promising.

The development of such a vaccine substance in such a short period of time and the results of clinical examination are incredible,” he said. Florian Krammer, a professor in the Department of microbiology at Mount Sinai in the US, described the clinical research results announced by BioNTech and Pfizer as “a great result.” Marylyn Addo, head of the Department of Tropical Diseases at the Eppendorf Clinic of the University of Hamburg, gave a more careful assessment and stressed that no primary data has yet come in, all data should be evaluated.

Many years of research as well as vaccines against infectious diseases for the first time in 10 months in the history of humanity and the development of a vaccine against the coronavirus that’s effective in over 90 percent is seen as a miracle.

A professor who believes that he has developed the most excellent vaccine against coronavirus “We are on the verge of ending this epidemic,” he said. The German press has already declared Prof Shahin the person who will lead the world out of the crisis. The Bild newspaper used the headline “father of the German vaccine wonder” for Prof Dr Uğur Şahin. The Express newspaper published in Cologne used the title “savior of the world crisis”, commenting that if it is successful, it will also win the Nobel Prize in medicine.

Born in 1965 Alexander, Prof Uğur Şahin came to Cologne, Germany with his family at the age of 4. Uğur Şahin, whose father worked as a worker in the Ford factory, was very impressed by a documentary film he watched on the life of Paul Ehrlich, a German medical scientist who developed chemotherapy against cancer, and decided to study medicine. Sahin studied medicine at the University of Cologne, his wife, whom he met in Hamburg, Dr. He was working with Özlem Türeci on antibodies that switch to defense against diseased cells to beat cancer.

Couples received awards for their significant progress in this area. The couple, who even worked in the lab on their wedding day, were alarmed by the lung disease coronavirus, which originated in Wuhan, China. 55-year-old professor The hawk saw very quickly that this infection would not remain local and would quickly spread all over the world.

Prof Şahin immediately convened the board of Directors of BioNTech, which he founded in 2008 with his wife Dr Özlem Türeci, and said: “Our new task is to defeat this virus. It will be a humanitarian mission,” he said.

Prof Sahin and Dr Türeci put the study of drug development against cancer on the back burner for a while, rolling up their sleeves to develop an effective and safe vaccine against coronavirus.

Although the name of Dr. Özlem Türeci, whose father is a doctor from Istanbul, is not at the forefront, he plays an important role in vaccine studies and is the head of research.”the EU Commission will soon sign contracts with these companies to receive up to 300 million doses of the vaccine, “von der Leyen said. the phrase ” used.

BioNTech, the founder of Prof Dr Uğur şahin, who developed the coronavirus vaccine, and Pfizer, the US-based pharmaceutical company, will submit an application for approval for the coronavirus vaccine to the US later this month, following positive data.

Pfizer signed a $ 1.95 billion deal with the U.S. government in July. It was reported that the pricing of this vaccine, administered in two doses in the United States, will be $ 159 per dose, and two doses will be $ 318.

The two companies said in a statement that they plan to apply to the U.S. Food and Drug Administration for emergency approval later this month, noting that the finding is the result of the first independent analysis of any Covid-19 vaccine in Stage 3 trials, the last stage before commercial licensing.

Prof Sahin said he had no interest in increasing his stock and becoming one of the richest in the world.

In a statement, the views, the BioNTech CEO and co-founder Prof Dr Ugur Sahin, an analysis of the first phase of the work of the 3rd Global Vaccine Dec vaccine “Covid-19 provide evidence that can effectively prevent.” stating that, “this innovation is a victory for science and global cooperation efforts. the phrase ” used.

Prof Sahin said: “this is what we wanted to achieve 10 months ago when we set out on the journey to find the vaccine in question. Especially today, when we are all in the middle of a second wave of the epidemic and many of us are subject to restrictions, we understand more and more how important this milestone is on the road to ending this epidemic and restoring a sense of normality for all of us.”he made his assessment.

For Uğur Şahin and Özlem Türeci, co-founders of BioNTech, which developed the vaccine, the news of the “couple who saved the world” made headlines in the World Press.

Prof Shahin’s words,” we are on the verge of ending this epidemic, ” revived the deeply depressed world economy. “The end of the tunnel appeared,” economic experts said.

Germany is especially proud that such a vaccine was developed in Germany, while the professor who signed the vaccine The fact that Uğur Şahin and his wife Özlem Türeci are of immigrant origin showed how meaningless the recent debate against immigrants is and how much labor migration contributes to Germany.

The world economy was buoyed again by the news of financial markets, while the stock market rose for the first time since March. The Dax, a German stock index, rose 6.5 per cent to 13,297 points, and EuroStoxx50 closed up 7.4 per cent at 3439 points. It was the highest increase since March. “The end of the tunnel appeared,” German economic experts said. The economic damage will be lower than expected. We expect a better conjuncture,” he assessed.

Scientists also stressed that the vaccine, developed under the leadership of Prof Sahin, is very promising. Head of the Department of Infectious Diseases of the University of Cologne Prof. Gerd Faetkenheuer said, ” These data are very excellent and promising. The development of such a vaccine substance in such a short period of time and the results of clinical examination are incredible,” he said.

Florian Krammer, a professor in the Department of microbiology at Mount Sinai in the US, described the clinical research results announced by BioNTech and Pfizer as “a great result.”

Marylyn Addo, head of the Department of Tropical Diseases at the Eppendorf Clinic of the University of Hamburg, gave a more careful assessment and stressed that no primary data has yet come in, all data should be evaluated.

To date, vaccines developed against infectious diseases around the world have taken many years, and research results are expected for at least two years to see the side effect. For the first time in human history, the development of a vaccine against coronavirus in as little as 10 months and it is more than 90 percent effective, as well as no significant side effects, is considered a miracle.

The German press has already declared Prof Shahin the person who will save the world from the crisis. The Bild newspaper used the headline “father of the German vaccine wonder” for Prof Uğur Şahin. The Express newspaper published in Cologne used the title saviour of the world crisis, commenting that if it is successful, it will also win the Nobel Prize in medicine.

Prof. Shares of BioNTech, which is headed by Uğur Sahin and his wife Özlem Türeci, rose 20 percent. Prof. “We want to create value in the long term,” he said.

Prof Uğur Şahin was very impressed by a documentary film he watched on the life of Paul Ehrlich, the German medical scientist who developed chemotherapy against cancer, and decided to study medicine. Prof Sahin, who studied medicine at the University of Cologne, was working with his wife, Dr Özlem Türeci, who he met in Hamburg, on antibodies that switch to defence against diseased cells to beat cancer. Couples received awards for their significant progress in this area.

Even working at the lab on their wedding day, the pair were alarmed by the lung disease coronavirus, which originated in Wuhan, China. Prof Shaheen, 55, saw very quickly that the infection would not remain local and would spread rapidly all over the world. Prof Şahin immediately convened the board of Directors of BioNTech, which he founded with his wife Dr Özlem Türeci in 2008, and said: “Our new task is to defeat this virus. It will be a humanitarian mission,” he said. Prof Sahin and Dr Türeci put the study of drug development against cancer on the back burner for a while, rolling up their sleeves to develop an effective and safe vaccine against coronavirus. Even if the name of Özlem Türeci, whose father is a doctor from Istanbul, is not mentioned in the news, he plays an important role in vaccine studies and is the head of research.

“Today is a great day for science and humanity,” Albert Bourla, Pfizer’s chief executive, said in a statement.

BioNTech had previously announced plans to produce 100 million more doses of vaccines globally by the end of 2020 and about 1.3 billion by the end of 2021.

Pfizer and BioNTech had signed agreements with the United States, the European Union, the United Kingdom, Canada and Japan to supply the vaccine. The companies had signed a $ 1.95 billion contract to provide the U.S. government with 100 million doses of the vaccine starting this year.

After yesterday’s news, countries around the world also took action to get the vaccine.

Spain’s Health Minister said Pfizer and BioNTech expect the vaccine to reach their countries by early 2021, while Germany plans to buy 100 million doses of the vaccine.

In the US, Pfizer and BioNTech plan to use the vaccine in the country. Donald Trump, who lost the US elections yesterday, despite intense election agenda, has made a statement with the vaccine; US, coronavirus (Covid-19) SE of the epidemic coronavirus vaccine developed by Pfizer and BioNTech an initial dose of 100 million to 1 billion and bought $ 95 million announced it has paid. Shares of the US drugmaker are up 14 per cent today.

BioNTech-Pfizer’s Covid-19 vaccine, Ankara University Faculty of Medicine Department of anesthesia and reanimation faculty member and member of the Scientific Board Prof. Dr. Necmettin Ünal had conveyed his experiences. Unal explained that the vaccine itself does not cause side effects, and it will be observed by the company for 2 years after the vaccine.